drugset / Trial / NCT01263834
Results of Adjunctive Intraoperative Bevacizumab Injection on Trabeculectomy Outcome
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to evaluate the adjunctive effect of intratenon Bevacizumab on the result of trabeculectomy in primary term of intraocular pressure (IOP).
Timeline
- Start
- 2010-12
- Primary completion
- 2014-01
- Completion
- 2014-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bevacizumab | Monoclonal antibody | 1.25 unknown | Other |
| Comparator | Mitomycin C | Other / unclassified | 0.4 mg/ml | Other |